Comparison of some properties of pronethalol and propranolol.
作者信息
Black J W, Duncan W A, Shanks R G
出版信息
Br J Pharmacol Chemother. 1965 Dec;25(3):577-91. doi: 10.1111/j.1476-5381.1965.tb01782.x.
Abstract
摘要
相似文献
1
Comparison of some properties of pronethalol and propranolol.丙萘洛尔和普萘洛尔某些性质的比较。
Br J Pharmacol Chemother. 1965 Dec;25(3):577-91. doi: 10.1111/j.1476-5381.1965.tb01782.x.
2
Evaluation of sympathetic beta-receptor blockade by recording the rate of ventricular pressure rise in cats.通过记录猫心室压力上升速率来评估交感β受体阻滞情况。
Br J Pharmacol Chemother. 1967 May;30(1):23-9. doi: 10.1111/j.1476-5381.1967.tb02109.x.
3
The effects of ICI 50172, propranolol, pronethalol and MJ 1999 on beta-receptors.ICI 50172、普萘洛尔、丙萘洛尔和MJ 1999对β受体的作用。
Eur J Pharmacol. 1969 Oct;8(1):25-35. doi: 10.1016/0014-2999(69)90125-3.
4
5
The pharmacology of beta sympathetic blockade.β-交感神经阻滞的药理学
Am J Cardiol. 1966 Sep;18(3):308-16. doi: 10.1016/0002-9149(66)90047-6.
6
On the blood content of guinea-pig tissues.
Pharmacology. 1970;4(5):273-7. doi: 10.1159/000136147.
7
Pharmacological properties of tetrahydropapaveroline.四氢罂粟碱的药理特性。
J Pharm Pharmacol. 1967 Jan;19(1):45-51. doi: 10.1111/j.2042-7158.1967.tb07992.x.
8
Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.两种新物质Kö 1313和Kö 1366的β肾上腺素能阻断作用及心血管特性
J Pharmacol Exp Ther. 1971 Feb;176(2):339-49.
9
Comparison of some properties of pronethalol and propranolol. 1965.丙萘洛尔与普萘洛尔某些特性的比较。1965年。
Br J Pharmacol. 1997 Feb;120(4 Suppl):285-99; discussion 283-4. doi: 10.1111/j.1476-5381.1997.tb06809.x.
10
Selective blockade of adrenoceptive beta receptors in the heart.心脏中肾上腺素能β受体的选择性阻断。
Br J Pharmacol Chemother. 1968 Jan;32(1):201-18. doi: 10.1111/j.1476-5381.1968.tb00444.x.
引用本文的文献
1
Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.肾上腺素能受体：受体、配体及其临床用途，分子药理学和检测。
Handb Exp Pharmacol. 2024;285:55-145. doi: 10.1007/164_2024_713.
2
Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders.β-肾上腺素受体亚型在人类心血管疾病中的作用及治疗：心力衰竭、心动过速性心律失常和其他心血管疾病。
Handb Exp Pharmacol. 2024;285:247-295. doi: 10.1007/164_2024_720.
3
Response of common bean ( L to lime and TSP fertilizer under acid soil.酸性土壤条件下普通菜豆（L）对石灰和过磷酸钙肥料的反应
Heliyon. 2023 Apr 6;9(4):e15176. doi: 10.1016/j.heliyon.2023.e15176. eCollection 2023 Apr.
4
Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence.关注差距——利用三维药效团和人工智能解析GPCR药理学
Pharmaceuticals (Basel). 2022 Oct 22;15(11):1304. doi: 10.3390/ph15111304.
5
Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中β受体阻滞剂的实用建议。
Expert Rev Respir Med. 2020 Jul;14(7):671-678. doi: 10.1080/17476348.2020.1752671. Epub 2020 Apr 19.
6
Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology.心内科中β-肾上腺素能阻滞剂的药代动力学变异性。
Pharmacol Res Perspect. 2019 Jul 12;7(4):e00496. doi: 10.1002/prp2.496. eCollection 2019 Aug.
7
Elevated endothelial Sox2 causes lumen disruption and cerebral arteriovenous malformations.内皮 Sox2 升高导致管腔破裂和脑动静脉畸形。
J Clin Invest. 2019 Jun 24;129(8):3121-3133. doi: 10.1172/JCI125965.
8
Rhodium(III)-Catalyzed [4+2] Annulation via C-H Activation: Synthesis of Multi-Substituted Naphthalenone Sulfoxonium Ylides.铑(III)催化的 C-H 活化[4+2]环加成反应：多取代萘并[2,3-d]噻吩砜亚胺叶立德的合成。
Molecules. 2019 May 16;24(10):1884. doi: 10.3390/molecules24101884.
9
ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker.第一幕——通过采用一种新型β受体阻滞剂，终于对癌症恶病质采取行动了。
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):400-2. doi: 10.1002/jcsm.12136. Epub 2016 Aug 5.
10
Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985).球囊血管成形术——安德烈亚斯·格里茨克医学博士的遗产（1939-1985）。
Front Cardiovasc Med. 2014 Dec 29;1:15. doi: 10.3389/fcvm.2014.00015. eCollection 2014.
本文引用的文献
1
Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118).辛可卡因（Su 3118）选择性释放外周去甲肾上腺素的药理学后果。
J Pharmacol Exp Ther. 1960 Feb;128:131-9.
2
THE MODIFICATION OF DIGITALIS INTOXICATION BY EXCLUDING ADRENERGIC INFLUENCES ON THE HEART.通过排除肾上腺素能对心脏的影响来改善洋地黄中毒。
J Pharmacol Exp Ther. 1964 Apr;144:97-103.
3
THE ANTI-ADRENERGIC PROPERTY OF NETHALIDE ON THE ISOLATED GUINEA-PIG LUNG.奈沙利定对离体豚鼠肺的抗肾上腺素能特性
Arch Int Pharmacodyn Ther. 1964 May 1;149:232-6.
4
THE CHRONOTROPIC AND VAGAL-BLOCKING ACTIONS OF NAPHTHYLISOPROTERENOL STUDIED BY DIRECT PERFUSION OF THE SINUS NODE.通过窦房结直接灌注研究萘异丙肾上腺素的变时性和迷走神经阻滞作用。
J Pharmacol Exp Ther. 1964 Mar;143:350-5.
5
THE EFFECT OF AN ADRENERGIC BETA-RECEPTOR ANTAGONIST ON THE CARDIOVASCULAR SYSTEM OF THE DOG.肾上腺素β受体拮抗剂对犬心血管系统的作用
J Pharmacol Exp Ther. 1964 Mar;143:344-9.
6
BETA-ADRENERGIC BLOCKADE WITH PRONETHALOL DURING ANAESTHESIA.
Br J Anaesth. 1964 Apr;36:224-32. doi: 10.1093/bja/36.4.224.
7
CARDIOVASCULAR EFFECTS OF CATECHOLAMINES IN DOGS BEFORE AND AFTER BETA-ADRENERGIC BLOCKADE.犬β-肾上腺素能阻断前后儿茶酚胺的心血管效应
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 Jan 10;246:297-308. doi: 10.1007/BF00247392.
8
A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.一种新型肾上腺素能β受体拮抗剂。
Lancet. 1964 May 16;1(7342):1080-1. doi: 10.1016/s0140-6736(64)91275-9.
9
THE EFFECTS OF SYMPATHECTOMY ON THE ELECTROCARDIOGRAM AND EFFORT TOLERANCE IN ANGINA PECTORIS.交感神经切除术对心绞痛患者心电图及运动耐量的影响。
Br Heart J. 1964 Mar;26(2):218-26. doi: 10.1136/hrt.26.2.218.
10
THE HAEMODYNAMIC EFFECTS OF BETA-SYMPATHETIC BLOCKADE.β-交感神经阻滞的血流动力学效应
Br Heart J. 1964 Mar;26(2):213-7. doi: 10.1136/hrt.26.2.213.
Zotero 插件